- Report
- November 2021
- 73 Pages
Global
From €6178EUR$6,995USD£5,277GBP
- Report
- September 2021
- 52 Pages
Global
From €4412EUR$4,995USD£3,768GBP
- Report
- June 2021
- 110 Pages
Global
From €6178EUR$6,995USD£5,277GBP
- Report
- March 2021
- 45 Pages
Global
From €2204EUR$2,495USD£1,882GBP
- Report
- March 2020
- 121 Pages
Global
From €13244EUR$14,995USD£11,313GBP
- Report
- December 2019
- 104 Pages
Asia Pacific
From €7944EUR$8,995USD£6,786GBP
- Report
- October 2019
- 157 Pages
Global
From €13244EUR$14,995USD£11,313GBP
- Report
- January 2021
- 148 Pages
China, Global
From €3000EUR$3,639USD£2,652GBP
- Report
- April 2024
- 140 Pages
Global
From €4371EUR$4,949USD£3,734GBP
- Report
- September 2023
- 160 Pages
Global
From €3179EUR$3,599USD£2,715GBP
- Report
- May 2023
- 147 Pages
Global
From €4371EUR$4,949USD£3,734GBP
- Report
- July 2023
- 115 Pages
Global
From €3974EUR$4,500USD£3,395GBP
- Report
- August 2022
- 120 Pages
Global
From €3974EUR$4,500USD£3,395GBP
- Report
- February 2024
- 177 Pages
Global
€4412EUR$4,995USD£3,768GBP
- Report
- January 2024
- 106 Pages
Global
€4412EUR$4,995USD£3,768GBP
- Report
- August 2023
- 80 Pages
Saudi Arabia
From €1325EUR$1,500USD£1,132GBP
- Report
- August 2023
- 80 Pages
India
From €1325EUR$1,500USD£1,132GBP
- Report
- August 2023
- 255 Pages
Global
From €2208EUR$2,500USD£1,886GBP
- Report
- August 2023
- 51 Pages
United Kingdom
From €397EUR$450USD£339GBP
€530EUR$600USD£453GBP
- Report
- August 2023
- 51 Pages
Australia
From €397EUR$450USD£339GBP
€530EUR$600USD£453GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more